U.S. flag

An official website of the United States government

NM_153700.2(STRC):c.3218G>A (p.Arg1073Gln) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Nov 25, 2015
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000151959.5

Allele description [Variation Report for NM_153700.2(STRC):c.3218G>A (p.Arg1073Gln)]

NM_153700.2(STRC):c.3218G>A (p.Arg1073Gln)

Gene:
STRC:stereocilin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
15q15.3
Genomic location:
Preferred name:
NM_153700.2(STRC):c.3218G>A (p.Arg1073Gln)
HGVS:
  • NC_000015.10:g.43611236C>T
  • NG_011636.1:g.12565G>A
  • NM_153700.2:c.3218G>AMANE SELECT
  • NP_714544.1:p.Arg1073Gln
  • NC_000015.9:g.43903434C>T
Protein change:
R1073Q
Links:
dbSNP: rs727503449
NCBI 1000 Genomes Browser:
rs727503449
Molecular consequence:
  • NM_153700.2:c.3218G>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
4

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000200492Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(LMM Criteria)
Uncertain significance
(Nov 25, 2015)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot provided44not providednot providednot providedclinical testing

Citations

PubMed

A systematic approach to assessing the clinical significance of genetic variants.

Duzkale H, Shen J, McLaughlin H, Alfares A, Kelly MA, Pugh TJ, Funke BH, Rehm HL, Lebo MS.

Clin Genet. 2013 Nov;84(5):453-63. doi: 10.1111/cge.12257.

PubMed [citation]
PMID:
24033266
PMCID:
PMC3995020

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000200492.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided4not providednot providedclinical testing PubMed (1)

Description

Variant classified as Uncertain Significance - Favor Benign. The p.Arg1073Gln va riant in STRC has been previously reported in three individuals with hearing los s (LMM unpublished data), one of whom had a pathogenic variant and the p.Cys1092 Tyr variant of uncertain significance in STRC; however, the cis/trans configurat ion of the variants was not determined. A second STRC variant was not detected i n the other two individuals (LMM unpublished data). This variant has been identi fied in 0.5% (4/888) of European chromosomes and in 0.4% (2/492) of South Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitut e.org; dbSNP rs727503449); however, this allele frequency is not high enough to rule out a pathogenic role. Computational prediction tools and conservation anal yses suggest that the variant may not impact the protein, though this informatio n is not predictive enough to rule out pathogenicity. In summary, while the clin ical significance of the p.Arg1073Gln variant is uncertain, the population frequ ency data suggests that it is more likely to be benign.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot provided4not provided4not provided

Last Updated: Aug 18, 2024